Prosthetic Joint Infection Clinical Trial
Official title:
Utility of Alpha Defensin and 16S rRNA Gene in Diagnosis of Prosthetic Joint Infection
Total joint replacement is considered one of the most successful surgical procedures in the
field of orthopedics. Despite this achievement, prosthetic joint infections is still
considered a severe complication often leading to catastrophic results and requiring repeated
and extensive treatment.
The incidence of PJI (a prosthetic joint infection) varies depending on the joint involved;
the rate of arthroplasties becoming infected is as follows: 1.7% of primary and 3.2%of
non-primary hip arthroplasties.
The accurate diagnosis of prosthetic joint infection often involves the combination of
multiple factors including symptoms, signs, synovial fluid cell count, serum inflammatory
markers, and culture.
The sensitivity of synovial fluid culture is only 85%, so a negative culture does not rule
out infection. However, the specificity of synovial fluid culture is approximately 95%, and
positive cultures often imply the presence of prosthetic joint infection.
The synovial fluid alpha-defensin test is an immunoassay that was specifically developed to
aid in the diagnosis of prosthetic joint infection .
The sensitivity and the specificity of the alpha-defensin immunoassay test have been reported
to be above 96%.
Molecular diagnostic tests using polymerase chain reaction (PCR) are emerging as a tool for
the diagnosis of infections and noninfectious conditions. The application of PCR techniques
with primers derived from the highly conserved regions of the bacterial 16S rRNA gene has
been useful in the detection of bacterial organisms.
Use of broad-range 16S rRNA gene PCR as a tool for identification of bacteria is possible
because the 16S rRNA gene is present in all bacteria .
Aim of the work:
.Determine sensitivity and specificity of alpha defensing and 16S rRNA gene in diagnosis of
prosthetic joint infection.
- Detection of antibiotic sensitivity for different organisms isolated from synovial fluid
Status | Recruiting |
Enrollment | 90 |
Est. completion date | January 1, 2020 |
Est. primary completion date | January 1, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - The study will include all patient with prosthetic joint suspected to be infected through clinical manifestation (fever, pain, fistula redness, swelling ,hotness and loss of function) associated with radiological evidence. Exclusion Criteria: - Any patient began antibiotic treatment will be excludes from the samples. |
Country | Name | City | State |
---|---|---|---|
Egypt | Ayat Bakhet Mostafa | Assuit |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Egypt,
Dudareva M, Barrett L, Figtree M, Scarborough M, Watanabe M, Newnham R, Wallis R, Oakley S, Kendrick B, Stubbs D, McNally MA, Bejon P, Atkins BA, Taylor A, Brent AJ. Sonication versus tissue sampling for diagnosis of prosthetic joint and other orthopaedic device-related infections. J Clin Microbiol. 2018 Sep 12. pii: JCM.00688-18. doi: 10.1128/JCM.00688-18. [Epub ahead of print] — View Citation
Slullitel PA, Oñativia JI, Buttaro MA, Sánchez ML, Comba F, Zanotti G, Piccaluga F. State-of-the-art diagnosis and surgical treatment of acute peri-prosthetic joint infection following primary total hip arthroplasty. EFORT Open Rev. 2018 Jul 17;3(7):434-441. doi: 10.1302/2058-5241.3.170032. eCollection 2018 Jul. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Diagnostic value of Alpha defensin in diagnosis of Prosthetic joint infection | value of measuring Alpha defensin by enzyme linked immunosorbent assay (ELISA) in diagnosis of Prosthetic joint infection as a rapid bio marker | 2 days | |
Primary | Diagnostic value of 16S rRNA gene in diagnosis of Prosthetic joint infection | value of measuring 16S rRNA gene by conventional PCR in diagnosis of Prosthetic joint infection as more accurate test | 2 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04067843 -
Effect of Photodynamic Treatment on Skin Microbiome. Single Center Study
|
N/A | |
Enrolling by invitation |
NCT05247281 -
NGS vs Culture Outcomes for Treatment of PJI
|
N/A | |
Withdrawn |
NCT05269121 -
Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections
|
Phase 1/Phase 2 | |
Recruiting |
NCT02801253 -
Cohort of Prosthetic Joint Infections
|
||
Completed |
NCT03694925 -
Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Revision Total Knee Arthroplasty
|
||
Completed |
NCT03721328 -
Safety and Efficacy in Patients Treated for Hip or Knee PJI With Vancomycin and Tobramycin Joint Irrigation
|
Phase 2 | |
Withdrawn |
NCT04787250 -
Bacteriophage Therapy in Patients With Prosthetic Joint Infections
|
Phase 1/Phase 2 | |
Recruiting |
NCT03307109 -
Quality of Life in Patients Having a Prosthetic Joint Infection
|
||
Recruiting |
NCT04661345 -
Identification of Molecular Marker of Coagulase-negative Staphylococci for the Diagnosis of Prosthetic Joint Infections
|
||
Recruiting |
NCT02805803 -
Quality of Life Assessment in Patients Undergoing Prolonged Suppressive Antibiotherapy for Prosthetic Joint Infection.
|
N/A | |
Completed |
NCT02413034 -
The Influence of Antibiotic Prophylaxis on Intraoperative Prosthetic Joint Infection Cultures
|
N/A | |
Recruiting |
NCT03784807 -
New Strategies for Biofilm Related Infections
|
||
Completed |
NCT04662632 -
Abbreviated Protocol for Two-Stage Exchange
|
Phase 2 | |
Not yet recruiting |
NCT04390607 -
Leukocyte Esterase Sensor Test
|
||
Recruiting |
NCT04650607 -
Phage Safety Cohort Study
|
||
Active, not recruiting |
NCT04946500 -
Clindamycin in Prosthetic Joint Infections Caused by Staphylococcus (CISTA)
|
||
Recruiting |
NCT04762706 -
Measuring Distress in Prosthetic Joint Infection Using a Standardized Metric: CRUTCH Pathway Pilot.
|
N/A | |
Withdrawn |
NCT05269134 -
Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)
|
Phase 2 | |
Not yet recruiting |
NCT05239312 -
Antibiogram and Biofilm Formation of Bacteria Causing Prosthetic Joint Infections Isolated From Assiut University Hospital
|
||
Completed |
NCT04294862 -
Tissue Distribution, Pharmacokinetics, Safety, and Tolerability After a Single Dose of TNP-2092 in Participants Undergoing Primary Total Hip or Knee Arthroplasty
|
Phase 1 |